{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Placebo+Formulation&page=7", "query": { "intervention": "Placebo Formulation", "page": 7 }, "page_size": 10 }, "pagination": { "page": 7, "page_size": 10, "total_count": 810, "total_pages": 81, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Placebo+Formulation&page=8&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Placebo+Formulation&page=6&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-22T07:00:50.931Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT02748694", "title": "Phase 1 TAK-041 First-in-Human Safety, Tolerability, and Pharmacokinetics Study", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Healthy Volunteers", "Schizophrenia" ], "interventions": [ { "name": "TAK-041", "type": "DRUG" }, { "name": "TAK-041 Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Neurocrine Biosciences", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "55 Years", "sex": "ALL", "summary": "18 Years to 55 Years" }, "enrollment_count": 114, "start_date": "2016-05-09", "completion_date": "2019-09-22", "has_results": true, "last_update_posted_date": "2021-03-19", "last_synced_at": "2026-10-22T07:00:50.931Z", "location_count": 1, "location_summary": "Glendale, California", "locations": [ { "city": "Glendale", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT02748694" }, { "nct_id": "NCT07542756", "title": "A SMART Approach to Evaluating the Benefits of Common Prescription and OTC Medications for Insomnia", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Insomnia", "Insomnia Disorder", "Chronic Insomnia", "Chronic Insomnia Disorder" ], "interventions": [ { "name": "Sleep Hygiene Education", "type": "OTHER" }, { "name": "Melatonin IR, 3 mg", "type": "DIETARY_SUPPLEMENT" }, { "name": "Melatonin IR, 5 mg", "type": "DIETARY_SUPPLEMENT" }, { "name": "Diphenhydramine, 25 mg", "type": "DRUG" }, { "name": "Diphenhydramine, 50 mg", "type": "DRUG" }, { "name": "Doxepin, 3 mg", "type": "DRUG" }, { "name": "Doxepin, 6 mg", "type": "DRUG" }, { "name": "Trazodone, 50 mg", "type": "DRUG" }, { "name": "Trazodone, 100 mg", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" }, { "name": "Zolpidem, 5 mg", "type": "DRUG" }, { "name": "Zolpidem, 10 mg", "type": "DRUG" } ], "intervention_types": [ "OTHER", "DIETARY_SUPPLEMENT", "DRUG" ], "sponsor": "University of Pennsylvania", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "80 Years", "sex": "ALL", "summary": "18 Years to 80 Years" }, "enrollment_count": 1200, "start_date": "2026-05-01", "completion_date": "2032-01-01", "has_results": false, "last_update_posted_date": "2026-09-16", "last_synced_at": "2026-10-22T07:00:50.931Z", "location_count": 1, "location_summary": "Philadelphia, Pennsylvania", "locations": [ { "city": "Philadelphia", "state": "Pennsylvania" } ], "official_url": "https://clinicaltrials.gov/study/NCT07542756" }, { "nct_id": "NCT02927873", "title": "A Study to Evaluate Safety, Reactogenicity and Immunogenicity of GSK Biologicals' RSV Investigational Vaccine Based on Viral Proteins Encoded by Chimpanzee-derived Adenovector (ChAd155-RSV) (GSK3389245A) in RSV-seropositive Infants", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Respiratory Syncytial Virus Infections" ], "interventions": [ { "name": "RSV (GSK3389245A) low dose formulation vaccine", "type": "BIOLOGICAL" }, { "name": "RSV (GSK3389245A) middle dose formulation vaccine", "type": "BIOLOGICAL" }, { "name": "RSV (GSK3389245A) high dose formulation vaccine", "type": "BIOLOGICAL" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "BIOLOGICAL", "DRUG" ], "sponsor": "GlaxoSmithKline", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "12 Months", "maximum_age": "23 Months", "sex": "ALL", "summary": "12 Months to 23 Months" }, "enrollment_count": 107, "start_date": "2017-01-11", "completion_date": "2020-11-26", "has_results": true, "last_update_posted_date": "2021-10-28", "last_synced_at": "2026-10-22T07:00:50.931Z", "location_count": 6, "location_summary": "Anaheim, California • Aurora, Colorado • Topeka, Kansas + 3 more", "locations": [ { "city": "Anaheim", "state": "California" }, { "city": "Aurora", "state": "Colorado" }, { "city": "Topeka", "state": "Kansas" }, { "city": "Frederick", "state": "Maryland" }, { "city": "Syracuse", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT02927873" }, { "nct_id": "NCT06310551", "title": "First Time in Human Study of Long Acting VH4524184 Formulations", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "HIV Infections" ], "interventions": [ { "name": "Oral VH4524184", "type": "DRUG" }, { "name": "VH4524184 Formulation A SC", "type": "DRUG" }, { "name": "Placebo Formulation A SC", "type": "DRUG" }, { "name": "rHuPH20", "type": "DRUG" }, { "name": "VH4524184 Formulation B SC", "type": "DRUG" }, { "name": "Placebo Formulation B SC", "type": "DRUG" }, { "name": "VH4524184 Formulation A IM", "type": "DRUG" }, { "name": "Placebo Formulation A IM", "type": "DRUG" }, { "name": "VH4524184 Formulation B IM", "type": "DRUG" }, { "name": "Placebo Formulation B IM", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "ViiV Healthcare", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "55 Years", "sex": "ALL", "summary": "18 Years to 55 Years" }, "enrollment_count": 372, "start_date": "2024-03-21", "completion_date": "2028-01-21", "has_results": false, "last_update_posted_date": "2026-08-10", "last_synced_at": "2026-10-22T07:00:50.931Z", "location_count": 3, "location_summary": "Lenexa, Kansas • San Antonio, Texas • Salt Lake City, Utah", "locations": [ { "city": "Lenexa", "state": "Kansas" }, { "city": "San Antonio", "state": "Texas" }, { "city": "Salt Lake City", "state": "Utah" } ], "official_url": "https://clinicaltrials.gov/study/NCT06310551" }, { "nct_id": "NCT04935359", "title": "Study of Efficacy and Safety of NIS793 in Combination With Standard of Care (SOC) Chemotherapy in First-line Metastatic Pancreatic Ductal Adenocarcinoma (mPDAC) - daNIS-2", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Metastatic Pancreatic Ductal Adenocarcinoma" ], "interventions": [ { "name": "NIS793", "type": "DRUG" }, { "name": "Nab-paclitaxel", "type": "DRUG" }, { "name": "Gemcitabine", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Novartis Pharmaceuticals", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "100 Years", "sex": "ALL", "summary": "18 Years to 100 Years" }, "enrollment_count": 511, "start_date": "2021-09-30", "completion_date": "2024-08-13", "has_results": true, "last_update_posted_date": "2026-05-19", "last_synced_at": "2026-10-22T07:00:50.931Z", "location_count": 9, "location_summary": "Fayetteville, Arkansas • Los Angeles, California • Orlando, Florida + 6 more", "locations": [ { "city": "Fayetteville", "state": "Arkansas" }, { "city": "Los Angeles", "state": "California" }, { "city": "Orlando", "state": "Florida" }, { "city": "Fort Wayne", "state": "Indiana" }, { "city": "New York", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT04935359" }, { "nct_id": "NCT07093580", "title": "Study of S-892216 Long-acting Injectable (LAI) in Healthy Adult Participants", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Healthy Participants" ], "interventions": [ { "name": "S-892216-LAI", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Shionogi", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "55 Years", "sex": "ALL", "summary": "18 Years to 55 Years" }, "enrollment_count": 128, "start_date": "2025-07-29", "completion_date": "2028-06-30", "has_results": false, "last_update_posted_date": "2026-10-16", "last_synced_at": "2026-10-22T07:00:50.931Z", "location_count": 3, "location_summary": "Cypress, California • Lenexa, Kansas • Salt Lake City, Utah", "locations": [ { "city": "Cypress", "state": "California" }, { "city": "Lenexa", "state": "Kansas" }, { "city": "Salt Lake City", "state": "Utah" } ], "official_url": "https://clinicaltrials.gov/study/NCT07093580" }, { "nct_id": "NCT06939868", "title": "Effect of a Cepham Supplement on Hot Flashes and Menopausal Symptoms in Postmenopausal Women", "overall_status": "NOT_YET_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "D008593" ], "interventions": [ { "name": "Shatavari Root Extract, oral capsule", "type": "DIETARY_SUPPLEMENT" } ], "intervention_types": [ "DIETARY_SUPPLEMENT" ], "sponsor": "Jacksonville University", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "40 Years", "maximum_age": "60 Years", "sex": "FEMALE", "summary": "40 Years to 60 Years · Female only" }, "enrollment_count": 44, "start_date": "2025-05-01", "completion_date": "2025-09-30", "has_results": false, "last_update_posted_date": "2025-04-23", "last_synced_at": "2026-10-22T07:00:50.931Z", "location_count": 1, "location_summary": "Jacksonville, Florida", "locations": [ { "city": "Jacksonville", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT06939868" }, { "nct_id": "NCT05805826", "title": "To Understand the Safety and Effects of a C. Difficile Vaccine With New Adds-Ons That Will Be Given to Healthy Adults", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Clostridoides Difficile Associated Disease" ], "interventions": [ { "name": "C. difficile vaccine (previously studied formulation).", "type": "BIOLOGICAL" }, { "name": "C. difficile vaccine formulation 1.", "type": "BIOLOGICAL" }, { "name": "C. difficile vaccine formulation 2.", "type": "BIOLOGICAL" }, { "name": "C. difficile vaccine formulation 3.", "type": "BIOLOGICAL" }, { "name": "Saline Placebo.", "type": "OTHER" } ], "intervention_types": [ "BIOLOGICAL", "OTHER" ], "sponsor": "Pfizer", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "50 Years", "maximum_age": null, "sex": "ALL", "summary": "50 Years and older" }, "enrollment_count": 936, "start_date": "2023-03-23", "completion_date": "2031-06-19", "has_results": false, "last_update_posted_date": "2026-04-29", "last_synced_at": "2026-10-22T07:00:50.931Z", "location_count": 23, "location_summary": "Phoenix, Arizona • Anaheim, California • Doral, Florida + 17 more", "locations": [ { "city": "Phoenix", "state": "Arizona" }, { "city": "Anaheim", "state": "California" }, { "city": "Doral", "state": "Florida" }, { "city": "Hialeah", "state": "Florida" }, { "city": "Hollywood", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT05805826" }, { "nct_id": "NCT01542632", "title": "A Comparison of the Safety and Immunogenicity of Various Schedules of Dengue Vaccine in Healthy Adult Volunteers", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Healthy" ], "interventions": [ { "name": "Takeda's Tetravalent Dengue Vaccine Candidate (TDV)", "type": "BIOLOGICAL" }, { "name": "TDV New Formulation", "type": "BIOLOGICAL" }, { "name": "Placebo", "type": "DRUG" }, { "name": "New Formulation Placebo", "type": "DRUG" } ], "intervention_types": [ "BIOLOGICAL", "DRUG" ], "sponsor": "Takeda", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "45 Years", "sex": "ALL", "summary": "18 Years to 45 Years" }, "enrollment_count": 140, "start_date": "2012-02-01", "completion_date": "2014-01-10", "has_results": true, "last_update_posted_date": "2019-07-18", "last_synced_at": "2026-10-22T07:00:50.931Z", "location_count": 3, "location_summary": "Fort Collins, Colorado • Galveston, Texas • West Jordan, Utah", "locations": [ { "city": "Fort Collins", "state": "Colorado" }, { "city": "Galveston", "state": "Texas" }, { "city": "West Jordan", "state": "Utah" } ], "official_url": "https://clinicaltrials.gov/study/NCT01542632" }, { "nct_id": "NCT02992314", "title": "Determination of the Safety and Effectiveness of an Oral Rinse in the Reduction of Medication Associated Metallic Taste", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Medication Associated Metallic Taste , Dysgeusia" ], "interventions": [ { "name": "Metaqil™ Oral Rinse", "type": "DEVICE" }, { "name": "Placebo", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "You First Services", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "18 Years to 75 Years" }, "enrollment_count": 52, "start_date": "2017-05-22", "completion_date": "2018-12-31", "has_results": false, "last_update_posted_date": "2021-01-22", "last_synced_at": "2026-10-22T07:00:50.931Z", "location_count": 1, "location_summary": "Buffalo, New York", "locations": [ { "city": "Buffalo", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT02992314" } ] }